Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Colorectal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Prostatic Neoplasms 1Neutropenia 1Neoplasms 1Mouth Neoplasms 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Lymphoma, B-Cell, Marginal Zone 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Febrile Neutropenia 1Adenocarcinoma 1

Interventions

Ciprofloxacin 3Ceftazidime 3Vancomycin 2Cefepime 2Amikacin 2pegylated granulocyte colony-stimulating factor 1Teicoplanin 1Tazobactam 1Piperacillin 1Ofloxacin 1Metronidazole 1Meropenem 1Levofloxacin 1Injections 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Febrile Neutropenia × Metronidazole × 1 year × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡